Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Accumulated Expenses: 2020-2023

Historic Accumulated Expenses for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $14.1 million.

  • Therapeutics' Accumulated Expenses fell 54.65% to $6.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.4 million, marking a year-over-year decrease of 54.65%. This contributed to the annual value of $14.1 million for FY2023, which is 62.93% up from last year.
  • As of FY2023, Therapeutics' Accumulated Expenses stood at $14.1 million, which was up 62.93% from $8.7 million recorded in FY2022.
  • In the past 5 years, Therapeutics' Accumulated Expenses registered a high of $14.1 million during FY2023, and its lowest value of $4.9 million during FY2020.
  • Its 3-year average for Accumulated Expenses is $9.7 million, with a median of $8.7 million in 2022.
  • Data for Therapeutics' Accumulated Expenses shows a peak YoY spiked of 62.93% (in 2023) over the last 5 years.
  • Over the past 4 years, Therapeutics' Accumulated Expenses (Yearly) stood at $4.9 million in 2020, then climbed by 28.19% to $6.3 million in 2021, then soared by 36.83% to $8.7 million in 2022, then soared by 62.93% to $14.1 million in 2023.